MXCT - MaxCyte GAAP EPS of -$0.05 beats by $0.01 revenue of $10.2M beats by $0.49M March, 22 2022 04:08 PM MaxCyte Inc. MaxCyte press release (NASDAQ:MXCT): Q4 GAAP EPS of -$0.05 beats by $0.01. Revenue of $10.2M (+18.6% Y/Y) beats by $0.49M. For further details see: MaxCyte GAAP EPS of -$0.05 beats by $0.01, revenue of $10.2M beats by $0.49M